Literature DB >> 3484324

In vivo activity of piritrexim [corrected] against Toxoplasma gondii.

F G Araujo1, D R Guptill, J S Remington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3484324     DOI： 10.1093/infdis/156.5.828

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Nobel lecture in physiology or medicine--1988. Selective inhibitors of dihydrofolate reductase.

Authors:  G H Hitchings
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

2.  Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolate.

Authors:  J A Kovacs; C J Allegra; J C Swan; J C Drake; J E Parrillo; B A Chabner; H Masur
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

3.  Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.

Authors:  G A Filice; C Pomeroy
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  In vitro effects of folate inhibitors on Toxoplasma gondii.

Authors:  F Derouin; C Chastang
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 5.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 6.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.